Generation of a novel ROR1 x CD3 bispecific T-cell engager for better tumor killing and minimal cytokine release

被引：2
|
作者：
Wu, Danqing
Gong, Shiyong
Wu, Xuan
Naren, Gaowa
Dong, Liqin
Lensky, Stephan
Wu, Chengbin
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-LB126
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB126
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A TRISPECIFIC ROR1 X CD3 T CELL ENGAGER MEDIATES IN VITRO TUMOR CELL KILLING AND IN VIVO TUMOR ERADICATION
    Chatterjee, Bithi
    Snell, Daniel
    Snell, Daniel
    Hess, Christian
    Brock, Matthias
    Spiga, Fabio
    Simonin, Alexandre
    Gunde, Tea
    Warmuth, Stefan
    Weinert, Christopher
    Bassler, Nicole
    Kirk, Niels
    Schumacher, Nina
    Mahler, Dana
    Yaman, Yasemin
    Bommer, Bettina
    Gambino, Giorgio
    Giezendanner, Noreen
    Kuettner, Benjamin
    Flueckiger, Naomi
    Heiz, Robin
    Wagen, Sandro
    Diem, Dania
    Zeberer, Julia
    Urech, David
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A885 - A885
  • [2] A ROR1 SPECIFIC CD3 BISPECIFIC T-CELL ENGAGER ENGINEERED FOR SOLID TUMORS WITH AN EXPANDED THERAPEUTIC WINDOW
    Rabinovich, Brian
    Zhou, Xueyuan
    Takimoto, Jeffrey
    Song, Paul
    Alici, Evren
    Khanna, Nikhita
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1110 - A1110
  • [3] A novel bispecific T-cell engager for targeting ROR1 positive malignancies
    Gohil, S. H.
    Moscosso, S. R. Paredes
    Harrasser, M.
    Sorio, C.
    Davidoff, A. M.
    Nathwani, A. C.
    Della Peruta, M.
    HUMAN GENE THERAPY, 2016, 27 (11) : A60 - A60
  • [4] Novel humanised ROR1 Bispecific T-cell Engager for the treatment of chronic lymphocytic leukaemia
    Gohil, Satyen
    Nathwani, Amit
    Harrasser, Micaela
    Paredes, Solange
    Della Peruta, Marco
    LEUKEMIA & LYMPHOMA, 2017, 58 : 230 - 231
  • [5] Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies
    Trinklein, Nathan D.
    Duy Pham
    Schellenberger, Ute
    Buelow, Ben
    Boudreau, Andrew
    Choudhry, Priya
    Clarke, Starlynn C.
    Dang, Kevin
    Harris, Katherine E.
    Iyer, Suhasini
    Jorgensen, Brett
    Pratap, Payal P.
    Rangaswamy, Udaya S.
    Ugamraj, Harshad S.
    Vafa, Omid
    Wiita, Arun P.
    van Schooten, Wim
    Buelow, Roland
    Aldred, Shelley Force
    MABS, 2019, 11 (04) : 639 - 652
  • [6] A CD3 x FRα T-cell engaging bispecific antibody for efficient killing of ovarian cancer cells with minimal cytokine release.
    Buelow, Ben
    Avanzino, Brian
    Balasubramani, Aarti
    Boudreau, Andrew
    Davison, Laura
    Ganesan, Priya
    Harris, Katherine
    Hartstein, Sharon
    Malik-Chaudhry, Harbani
    Pham, Duy
    Prabhakar, Kirthana
    Rangaswamy, Udaya
    Saiganesh, Sowmya
    Schellenberger, Ute
    Ugamraj, Harshad
    Kehm, Hannes
    Trinklein, Nathan
    Iyer, Suhasini
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Local Activator and T Cell Engager (αBCMA x αPD-L1 x αCD3) with Enhanced Tumor Killing and Minimal Cytokine Release for the Treatment of Multiple Myeloma
    Vrohlings, Melissa
    Jungmichel, Stephanie
    Mueller, Jan
    Senn, David
    Schleier, Thomas
    Scheifele, Fabian
    Wendelspiess, Severin
    Leisner, Christian
    Krauth, Maria-Theresa
    Jaeger, Ulrich
    Borras, Leonardo J.
    BLOOD, 2020, 136
  • [8] The Biodistribution of a CD3 and EpCAM Bispecific T-Cell Engager Is Driven by the CD3 Arm
    Suurs, Frans, V
    Lorenczewski, Grit
    Stienen, Sabine
    Friedrich, Matthias
    de Vries, Elisabeth G. E.
    de Groot, Derk Jan A.
    Lub-de Hooge, Marjolijn N.
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (11) : 1594 - 1601
  • [9] A novel T-cell bispecific antibody platform for efficient T-cell mediated killing of tumor cells with minimal cytokine release.
    Rangaswamy, Udaya
    Boudreau, Andrew
    Buelow, Ben
    Clarke, Starlynn
    Dang, Kevin
    Davison, Laura
    Aldred, Shelley Force
    Harris, Katherine
    Iyer, Suhasini
    Jorgensen, Brett
    Ogana, Heather
    Pham, Duy
    Pratap, Payal
    Trinklein, Nathan
    Schellenberger, Ute
    Ugamraj, Harshad
    Vafa, Omid
    Van Schooten, Wim
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [10] Microenvironment-responsive anti-PD-L1 x CD3 bispecific T-cell engager for solid tumor immunotherapy
    Liu, Dingkang
    Bao, Lichen
    Zhu, Haichao
    Yue, Yali
    Tian, Jing
    Gao, Xiangdong
    Yin, Jun
    JOURNAL OF CONTROLLED RELEASE, 2023, 354 : 606 - 614
12345